Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Covington
Chubb
McKesson
QuintilesIMS
Moodys
Healthtrust
Boehringer Ingelheim

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DALBAVANCIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Dalbavancin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00057369 Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections Unknown status Vicuron Pharmaceuticals Phase 2 This is a study to evaluate a new medication dosed once a week in the treatment of bacterial infections in the blood from intravenous catheters (CR-BSI). The primary objective is to evaluate the efficacy and safety of dalbavancin in the treatment of adults with CR-BSI relative to a standard of care treatment, vancomycin.
NCT00678106 Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections Completed Pfizer Phase 1 Adolescent subjects hospitalized for the treatment of bacterial infections will be given 1 gram of dalbavancin through their veins and levels of dalbavancin in blood and urine will be measured at different time points. Safety labs will also be checked on a regular basis to assess the safety of dalbavancin.
NCT01339091 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed Durata Therapeutics Inc., an affiliate of Allergan plc Phase 3 The primary object is to compare the early clinical efficacy (after 48-72 hours of therapy) of dalbavancin to the comparator regimen (vancomycin with the option to switch to oral linezolid) for the treatment of patients with a suspected or proven gram-positive bacterial skin or skin structure infection.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dalbavancin Hydrochloride

Condition Name

Condition Name for Dalbavancin Hydrochloride
Intervention Trials
Bacterial Infections 5
Osteomyelitis 4
Cellulitis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dalbavancin Hydrochloride
Intervention Trials
Infection 11
Communicable Diseases 10
Bacterial Infections 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dalbavancin Hydrochloride

Trials by Country

Trials by Country for Dalbavancin Hydrochloride
Location Trials
United States 84
South Africa 8
Russian Federation 7
Ukraine 4
Taiwan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dalbavancin Hydrochloride
Location Trials
California 7
Florida 6
New York 5
Louisiana 5
Ohio 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dalbavancin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dalbavancin Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 6
Phase 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dalbavancin Hydrochloride
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 5
Recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dalbavancin Hydrochloride

Sponsor Name

Sponsor Name for Dalbavancin Hydrochloride
Sponsor Trials
Durata Therapeutics Inc., an affiliate of Allergan plc 8
Allergan 5
University of Colorado, Denver 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dalbavancin Hydrochloride
Sponsor Trials
Industry 16
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fuji
Harvard Business School
Cerilliant
Federal Trade Commission
Accenture
McKinsey
Baxter
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.